Related Experiment Video
Updated: Jun 3, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
947
An Evolutionary Federated Learning Approach to Diagnose Alzheimer's Disease Under Uncertainty
Nanziba Basnin1, Tanjim Mahmud2, Raihan Ul Islam3
1Cybersecurity Laboratory, Luleå University of Technology, 97187 Luleå, Sweden.
Diagnostics (Basel, Switzerland)
|January 11, 2025
Summary
This study introduces a novel approach for early Alzheimer's disease (AD) diagnosis by integrating medical imaging and demographic data. Federated learning with a belief rule base achieved 99.9% accuracy, enabling scalable and private healthcare solutions.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Informatics
Background:
- Alzheimer's disease (AD) causes significant cognitive and functional decline, with its etiology still unclear.
- Early AD diagnosis is crucial for interventions to slow disease progression.
- This research addresses AD complexity using multimodal data integration (medical imaging and demographics).
Purpose of the Study:
- To develop a scalable, secure, and privacy-preserving system for Alzheimer's disease diagnosis.
- To integrate multimodal data (MRI, demographics) for improved diagnostic accuracy.
- To evaluate federated learning and belief rule base (BRB) for managing data uncertainty in AD.
Main Methods:
- A deep learning framework using Convolutional Neural Networks (CNNs) processed MRI images.
- Federated learning distributed data for local training across clients.
- A belief rule base (BRB) integrated multimodal data and managed uncertainty during training.
Main Results:
- Federated learning, specifically the FedAvg aggregation method, was evaluated.
- The model achieved a global accuracy of 99.9% in diagnosing Alzheimer's disease.
- The BRB framework effectively handled uncertainty in AD data integration.
Conclusions:
- The developed multimodal approach advances Alzheimer's disease diagnostics.
- Federated learning offers a scalable and privacy-preserving solution for healthcare.
- The BRB framework provides robust data integration and analysis for complex diseases like AD.
Related Concept Videos
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Associative Learning
287
Associative learning is a fundamental concept in behavioral psychology, wherein a connection is established between two stimuli or events, leading to a learned response. This process is critical in understanding how behaviors are acquired and modified. Conditioning, the mechanism through which associations are formed, can be divided into two main types: classical conditioning and operant conditioning, each elucidating different aspects of associative learning.
Classical conditioning, also known...
Classical conditioning, also known...
287

